| Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.5m in new equity financing, including £2.5m from lead investor |
7... revres SND a otni iP yrrebpsaRBudget... sputrats rof semehcs ,feiler xKerry... sliated tbed m4€ sraeh truoc sHow... oT tnaW d’uoY yhW dna -- sserdCrypto... srotaluger SU rehto xis dna aiFamilies... letoh PI egdirbweN ta gnivil nItching... eganaM oT syaW wonK :PCI oT euEnd... ceiwałseloB - 4A no srehto gnoGet... nosaes neewollaH siht robrA nnVisa... otpyrc ni stnahcrem yap pleh o